Human Rabies Vaccines Market Size, Share, Growth

Comments · 214 Views

The expected CAGR of the human rabies vaccines market tends to be around 4.7% in the mentioned forecast period. The market was valued at USD 963.53 million in 2022 and would grow to USD 1391.36 million by 2030.

"A dependable  Human Rabies Vaccines Market business report serves as the foundation for competitor analysis, thoroughly examining their core competencies and creating a competitive landscape for the market. This data is crucial for businesses when formulating strategies for the production, marketing, sales, promotion, and distribution of products and services. The market report is highly suitable for various business requirements and also facilitates informed decision-making and efficient operations. To obtain actionable market insights and profitable business strategies, an ideal market research report like the Human Rabies Vaccines Market analysis report is essential.

A team of multi-lingual analysts, project managers, and skilled experts supports clients in every strategic aspect, including product development, key areas of development, application modeling, technology utilization, acquisition strategies, exploring niche growth opportunities, and new markets. A high-quality Human Rabies Vaccines Market research report has been curated for the success of businesses even at the international level. The research and analysis conducted in this market report help businesses envision investments in emerging markets, expand market share, or launch a new product with the assistance of global market research analysis.

Increasing global incidences of mortality because of rabies, the increasing issue of stray dogs in countries with low economic development are projected to drive the market over the predicted years. According to WHO, rabies cause fatalities approximately 10,000 people every year worldwide and almost 99% cases are because of dog bites. According to World Health Organization, rabies caused 59,000 deaths annually in 150 countries with 95% cases in rural districts in 2017.

Data Bridge Market Research analyses a growth rate in the human rabies vaccines market in the forecast period 2023-2030. The expected CAGR of the human rabies vaccines market tends to be around 4.7% in the mentioned forecast period. The market was valued at USD 963.53 million in 2022 and would grow to USD 1391.36 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Explore Further Details about This Research Human Rabies Vaccines Market Report

Human Rabies Vaccines Market Scope and Segmentation



Forecast Period

2023 to 2030

Base Year


Historic Years

2021(Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Cell Line Type (Chick Embryo Cells, Vero Cell, BHK Cells, and Other), Application (Pre Exposure Prophylaxis and Post Prophylaxis), Route of Administration (Intravenous and Subcutaneous), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Serum Institute of India Pvt. Ltd (India), Novartis AG (Switzerland), Cadila Pharmaceuticals (India), and Merck & Co., Inc. (U.S.), Sanofi (France), ADS Diagnostic Ltd (India), GSK plc (U.K.), Berna Biotech Pharma GmbH (Switzerland), and AstraZeneca (U.K.)

Market Opportunities

  • Growing R&D Activities
  • Increasing Healthcare Expenditure
Market Definition

Rabies is typically characterized as a severe disease that is caused by the rabies virus. The humans are most likely to be infected through animal bites such as dogs, cats, bats, and other mammals. The central nervous system is affected by the rabies virus which causes severe impact to the brain and may ultimately cause death in serious cases. The major symptoms include anxiety, hallucination, insomnia, hydrophobia, paralysis hyper salivation, and others. Henceforth, early prevention from the rabies is vital with the help of vaccines.

Global Human Rabies Vaccines Market Dynamics


  • Rise In The Incidence Of Rabies

The incidence of rabies is leading to a growth in the vaccine production which boosts the growth of the market. For instance, in the U.S., rabies from early 1960 to 2000 was insignificant, and a sudden rise resulted in 100 cases yearly.  Although the fatalities were rare, lack of awareness towards rabies is proving to be a huge risk. From 1960 to 2018, 127 cases of rabies were stated in U.S. from dog bites and bat bites. However in Asia, rabies is a major burden, resulting for almost 35,000 deaths, fatalities caused by rabies in India are 55%.

  • Increasing Technological Developments of Vaccines

There are various technological developments that are associated with the market which boost the growth of the market. For instance, in February 2018, BioNote, Inc., a South Korean veterinary diagnostic company that is operating in rabies diagnostics, announced the launch of a new immune-fluorescent device, Vcheck, that can measure diagnostic result values along with the help of fluorescent materials that helps in detecting the zoonotic disease in animals. Thus, these factors are expected to fuel the market growth in the coming years.


  • Growing R&D Activities

Several market players are focused on research and development strategies that are expected to boost the market growth during the forecast period. For instance, in 2017, CPL Laboratories (India) which is a joint venture biotechnology company established in 2009 by Novavax Inc., USA and Cadila Pharmaceuticals Limited, stated that Nano-particle vaccine of baculvirous-derived glycoprotein which is a four dose regime vaccine is in phase-3 human trial, and is projected to be approved by 2021.

  • Increasing Healthcare Expenditure

Growing healthcare expenditure by several organizations lead to the market expansion. For instance, in April 2022, the disease prevention and control bureau, Department of Health, Philippines, awarded Metro Drugs Inc., a procurement contract for 2,500,000 doses of purified chick embryo cell rabies vaccine. The total approved budget for this contract is 200,000,000 PHP.

Key Influence of this  Human Rabies Vaccines Market:

  • Comprehensive assessment of all opportunities and risk in this Human Rabies Vaccines Market
  • This Market recent innovations and major events
  • Detailed study of business strategies for growth of the this Market-leading players
  • Conclusive study about the growth plot of the Human Rabies Vaccines Market for forthcoming years
  • In-depth understanding of this Human Rabies Vaccines Market particular drivers, constraints and major micro markets
  • Favourable impression inside vital technological and market latest trends striking this Market
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World (ROW)
  • To provide country level analysis of the market with respect to the current market size and future prospective

Browse Related Reports:

Vinca Alkaloids Drugs Market To Perceive Highest Growth of Billion by Size, Share, Trends, Key Growth Drivers and Opportunity Analysis

Anti-CD19 Therapeutic Antibody Market to Receive Billion by Size, Shares, Trends, Demand, Growth Opportunities and Revenue Analysis

Erectile Dysfunction Treatment Market to Experience Substantial Growth of Billion by  Size, Share, Demand, Opportunities, Growth Rate and Key Players Analysis

Hereditary Hemorrhagic Telangiectasia disease Market is expected to Reach the Valuation Billion by Size, Share, Growth, Trends, Demand and Opportunity Analysis

Malaria Treatment Market to Grasp Outstanding Growth of Million by, Size, Share, Trends, Opportunities, Key Drivers and Revenue Forecast

Netherton Syndrome Market to Exhibit an Incredible Growth of Billion by Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis

Catheter Associated Urinary Tract Infection Treatment Market is Probable to Influence the Value of Billion by Size, Share, Trends, Industry Growth and Competitive Outlook

macular degeneration treatment Market to Receive Highest Growth of Billion by Size, Shares, Trends, Future Demand, Growth and Revenue Analysis

Myelodysplasia Treatment Market to Grasp Outstanding Growth of Billion by Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus

Neurofibromatosis Market to Observe Prominent CAGR Growth by Size, Share, Trends, Demand, Growth and Competitive Analysis

About Data Bridge Market Research:

 US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]